When should we be starting therapy in GCA and PMR? The problem with having therapies that work is that you then have to figure out what to do with them. You cannot hide behind the ambiguity of therapeutic inadequacy. https://t.co/oRWTeH5Q9h https://t.co/BbswdffoKM

Save the date for RheumNow Live 2024, on January 27-28, in Dallas, TX, or from the comfort of your own space through our virtual platform! Why choose RheumNow Live? Because this isn't just another conference – it's a revolution in medical education! https://t.co/K2YYqjjs8F https://t.co/MinRm9N9rz

Health disparities in SLE reviewed disparities by Parodis et al. Racial and ethnic influences on manifestations and outcomes reviewed, along with common pitfalls in studies, along w/ proposed framework for research on health disparities in SLE (full read) https://t.co/7GvzttR9HZ https://t.co/wYGiMg4zqK

Promising Therapies for Sjogren's Dr. Yuz Yusof discusses abstracts 1634 at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/8iSDMKtKwa https://t.co/QCYTnpYKFN

ICYMI: SpA Sleuths: The Case of Undiagnosed IBD As rheumatologists, we are medical detectives investigating complex and often elusive autoimmune and inflammatory conditions https://t.co/dE0NLXKDvT https://t.co/DalUXRf3MB

CBT or Naltrexone in Fibromyalgia https://t.co/9SGRbY97oD https://t.co/wN2cMuqgHa

Expert consensus(ASAS) prefers SpondyloArthritis(axSpA) as preferred over "ankylosing spondylitis" (historic but no longer appropriate based on MRI research showing this is more than SI disease). AS radiographic axSpA(r-axSpA) can be used interchangeably https://t.co/jvT3lQFaPq https://t.co/WRNrbfjK1S

Danish study compared 106K adults w/ major osteoporotic fracture (hip, vertebrae, wrist, humerus) vs 1+ mill controls & found Mortality highest 30d following 1st index hip Fx (HR 10.98 women; & HR 16.40 men). Pneumonia most common cause of mortality https://t.co/0D7ynN4f5L https://t.co/qX61cgq1SL

Hemophagocytic Lymphohistiocytosis in Still's disease Dr. Bella Mehta discusses abstract 1143, presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/AFoKm6kT86 https://t.co/dLTjTOdbmv

Watch: Non-TNFi b/tsDMARDs vs. TNFi in RA-ILD https://t.co/fOz4jH58r9 https://t.co/jSHnsZscPg

Cardiology 101 for the Rheumatologist Dr. Janet Pope reports on a cardiology session presented a 2023 ACR Convergence in San Diego, CA https://t.co/0cS8JVneIG https://t.co/6SIPx6WmqX

FDA Warning on CAR-T Cell Therapy The FDA issued a safety alert on CAR-T cell immunotherapies; noting reports of T-cell malignancies (CAR-positive lymphoma) arising in patients treated with BCMA- or CD19-directed autologous CAR T cell immunotherapies. https://t.co/1OiMWJMskz https://t.co/8i8LFMcb1s